Gujarat Inject (Kerala) Limited (BOM:524238)
India · Delayed Price · Currency is INR 40.08
+0.69 (1.75%)
At close: Jan 20, 2026
Gujarat Inject (Kerala) Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 2.27 | 0.26 | 29.19 | 0.62 | 0.08 | 0.08 | Upgrade |
Cash & Short-Term Investments | 2.27 | 0.26 | 29.19 | 0.62 | 0.08 | 0.08 | Upgrade |
Cash Growth | 48.53% | -99.10% | 4633.05% | 721.31% | -11.65% | -32.67% | Upgrade |
Accounts Receivable | 70.43 | 71.8 | 29.77 | - | - | - | Upgrade |
Receivables | 70.43 | 99.49 | 57.66 | - | - | - | Upgrade |
Inventory | - | - | - | - | 0.09 | 0.03 | Upgrade |
Other Current Assets | 0.06 | - | - | 0.09 | 0.08 | - | Upgrade |
Total Current Assets | 72.76 | 99.75 | 86.85 | 0.7 | 0.24 | 0.12 | Upgrade |
Long-Term Investments | - | - | - | - | 0.02 | 0.02 | Upgrade |
Long-Term Accounts Receivable | - | - | - | 2.33 | 0.39 | 0.05 | Upgrade |
Total Assets | 116.98 | 119.51 | 86.85 | 3.03 | 0.65 | 0.18 | Upgrade |
Accounts Payable | 12.2 | 16.71 | 1.1 | 3.23 | - | - | Upgrade |
Accrued Expenses | 3.19 | 2.68 | 0.3 | 2.1 | - | 1.98 | Upgrade |
Short-Term Debt | - | - | - | 1.93 | 4.15 | 2.77 | Upgrade |
Current Income Taxes Payable | - | - | - | - | - | 0.08 | Upgrade |
Other Current Liabilities | 0.05 | - | - | - | - | - | Upgrade |
Total Current Liabilities | 15.44 | 19.38 | 1.4 | 7.25 | 4.15 | 4.83 | Upgrade |
Long-Term Debt | - | - | - | 4.15 | 48.85 | 4.15 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | - | - | -57.63 | - | Upgrade |
Other Long-Term Liabilities | - | -0 | - | - | 14.09 | - | Upgrade |
Total Liabilities | 15.44 | 19.38 | 1.4 | 11.41 | 9.45 | 8.98 | Upgrade |
Common Stock | 146.35 | 146.35 | 112.92 | 48.85 | 48.85 | 48.85 | Upgrade |
Additional Paid-In Capital | - | - | - | 34.08 | 34.08 | 34.08 | Upgrade |
Retained Earnings | - | - | - | -91.3 | -91.73 | -91.73 | Upgrade |
Comprehensive Income & Other | -44.81 | -46.22 | -27.47 | - | - | - | Upgrade |
Shareholders' Equity | 101.54 | 100.12 | 85.45 | -8.37 | -8.81 | -8.81 | Upgrade |
Total Liabilities & Equity | 116.98 | 119.51 | 86.85 | 3.03 | 0.65 | 0.18 | Upgrade |
Total Debt | - | - | - | 6.08 | 53 | 6.92 | Upgrade |
Net Cash (Debt) | 2.27 | 0.26 | 29.19 | -5.46 | -52.92 | -6.83 | Upgrade |
Net Cash Growth | 48.53% | -99.10% | - | - | - | - | Upgrade |
Net Cash Per Share | 0.27 | 0.03 | 3.17 | -1.07 | -10.80 | -1.39 | Upgrade |
Filing Date Shares Outstanding | 13.5 | 14.63 | 11.31 | 4.9 | 4.9 | 4.9 | Upgrade |
Total Common Shares Outstanding | 13.5 | 14.63 | 11.31 | 4.9 | 4.9 | 4.9 | Upgrade |
Working Capital | 57.32 | 80.37 | 85.45 | -6.55 | -3.91 | -4.72 | Upgrade |
Book Value Per Share | 7.52 | 6.84 | 7.56 | -1.71 | -1.80 | -1.80 | Upgrade |
Tangible Book Value | 101.54 | 100.12 | 85.45 | -8.37 | -8.81 | -8.81 | Upgrade |
Tangible Book Value Per Share | 7.52 | 6.84 | 7.56 | -1.71 | -1.80 | -1.80 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.